A major conference which has taken place in Belfast, Northern Ireland, has heard how more action is required to tackle a widening gap in the physical health of patients with mental health problems. The conference, which was organised by the Northern Ireland-based Medicines Optimisation Innovation Centre (MOIC), the Pharmacy Management organisation (www.pharman.co.uk) and sponsored by [...]
Janssen has announced that the Scottish Medicines Consortium (SMC) has accepted paliperidone palmitate (Trevicta®) for use within NHS Scotland. Paliperidone palmitate (Trevicta®), a three-monthly injection is indicated for the maintenance treatment of schizophrenia in adult patients who are clinically stable on one-monthly paliperidone palmitate injectable product. This new formulation of paliperidone palmitate is administered every [...]
It can take some time before anti-depressant drugs have an effect on people. Yet, the chemical changes that they cause in the brain happen quite rapidly. Understanding this paradox could enable us to create more effective treatments for depression. However, new research from a group of scientists at Oxford, Harvard and Limerick universities has shown [...]
A new method to find anti-depressant treatments that work for individual patients is about to be tested at GP surgeries across Europe. Researchers at the Oxford Health NHS Foundation Trust and Oxford University’s Department of Psychiatry, in collaboration with the Oxfordshire-based company P1vital Products Ltd, are conducting the PReDicT (Predicting Response to Depression Treatment) study. [...]
A new report from business intelligence provider GBI Research – Frontier Pharma: Schizophrenia and Associated Indications – states that although the schizophrenia market is replete with unmet needs and its pipeline is paltry, the overall level of innovation for schizophrenia-related indications – which comprise depression, panic disorders, obsessive compulsive disorder, post-traumatic stress disorder and cognitive [...]
Bookings are now open for CPPE’s workshop – Mental Capacity Act 2005 and covert administration of medicines. The workshop aims to develop your knowledge and skills to help you manage and optimise care for patients who might lack the mental capacity to make a specific decision relating to their medicines at a given point in time. [...]
According to research obtained from the NHS, Blackpool is the town in England which has recorded the most anti-depressants use – around £1.5 million worth has been supplied by the service. Also, the popular holiday destination has been reported as having the lowest life expectancy for men. In terms of anti-depressant spend per head, St [...]
